The Indian Journal of Pediatrics

, Volume 69, Issue 12, pp 1087–1089 | Cite as

Neonatal diabetes with hyperchylomicronemia

  • Zehra Aycan
  • Merih Berberoglu
  • Gönül Öcal
  • Nilgün Altundas
  • Pelin Adiyaman
  • Okay Evliyaoğlu
Clinical Brief


Neonatal diabetes mellitus (NDM) is defined as hyperglycemia occurring in the first few weeks of life. It can be either transient (TNDM) or permanent (PNDM). A 25 days old newborn was brought to the hospital with restlessness, respiratory depression and cyanosis. He was born at term with a birth weight of 2000 g. There was no consanguinity between his parents. His physical examination findings were as follows: Weight and height were under 3th percentile, he was hypoactive and dehydrated. Serum glucose level was 800 mgJdl; C-peptide was 0.41 ngJml. Upon investigation for dyslipidemia in association with his neonatal diabetes, hyperchylomicronemia was found both in the patient and his father. Pancreatitis, anemia and cholestasis were also observed. Insulin treatment was started for his diabetes together with a special diet for dyslipidemia. At the end of 28 months of follow-up, dyslipidemia has resolved but the need for insulin therapy was still existing. However, TNDM was considered in differential diagnosis because he was small for gestational age(SGA) at birth and his symptoms had started at the 25th day of the neonatal period. Delayed recovery from insulin dependency brought out the possibility of PNDM. Furthermore, neonatal diabetes combined with hypechylomicronemia is a rare clinical picture. Reported cases of NDM with different clinical evaluation will help to better understanding of this disorder.

Key words

Neonatal diabetes Hyperchylomicronemia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shield JPH. Neonatal diabetes: New insights into aetiology and implications.Horm Res 2000; 53(suppl 1): 7–11.PubMedCrossRefGoogle Scholar
  2. 2.
    Lifshitz F. The infant of a diabetic mother and diabetes in the first year of life. In Alicia A Romano, eds.Pediatric Endocrinology. Brooklyn-New York: Marcel Deccer, 1996; 572–581.Google Scholar
  3. 3.
    Menon PSN, Khatwa UA. Diabetes mellitus in newborns and infants.Indian J Pediatr 2000; 67:443–448.PubMedCrossRefGoogle Scholar
  4. 4.
    Kitselle JFJ. Kinderheilkunde 1852; 18:313.Google Scholar
  5. 5.
    Shield JPH, Gardner RJ, Wadsworth EJKet al. Neonatal diabetes: A study of its aetiopathology and genetic basis.Arch Dis Child 1997; 76: F39-F42.Google Scholar
  6. 6.
    Von Miihlendahl KE, Herkenhoff H. Long-term course of neonatal diabetes.N Engl J Med 1995; 333: 704–708.CrossRefGoogle Scholar
  7. 7.
    Fosel S. Transient and permanent neonatal diabetes.Eur J Pediatr 1995; 154: 944–948.PubMedCrossRefGoogle Scholar
  8. 8.
    Hermann R, Laine AP, Johansson Cet al. Transient but not permanent neonatal diabetes mellitus is associated with paternal uniparental isodisomy of chromosome 6.Pediatrics 2000; 105:49–52.PubMedCrossRefGoogle Scholar
  9. 9.
    Temple IK, Gardner RJ, Robinson DOet al. Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23.Hum Mol Genet 1996; 5:1117–1121.PubMedCrossRefGoogle Scholar
  10. 10.
    Knip M, Koivisto M, Kaar ML, Puukka R, Kouvalainen K. Pancreatic islet cell function and metabolic control in an infant with permanent neonatal diabetes.Acta Paediatr Scand 1983; 72: 303–307.PubMedCrossRefGoogle Scholar
  11. 11.
    Marquis E, Le Monnier de Gouville I, Bouvattier Cet al. HLA-DRBJ and DQB1 genotypes in patients with insulin-dependent neonatal diabetes mellitus. A study of 13 cases.Tissue Antigens 2000; 56:217–222.PubMedCrossRefGoogle Scholar
  12. 12.
    Mazzella M, Cotellessa M, Bonacci W, Bruno C, Serra G. Neonatal diabetes and DQB, typing.Diabetes Care 1996; 19: 1308.PubMedGoogle Scholar
  13. 13.
    Hoveyda N, Shield JPH, Garrett Cet al. Neonatal diabetes mellitus and cerebellar hypoplasiaJagenesis: Report of an association in three members of a consanguineous family.J Med Genet 1999; 36: 700–704.PubMedGoogle Scholar
  14. 14.
    Al-Gazali LI, Makia S, Azzam A, Hall CM. Wolcott-Rallison syndrome.Clin Dysmorphol 1995; 4:227–233.PubMedCrossRefGoogle Scholar
  15. 15.
    Gottschalk ME, Schatz DA, Clare-Salzler M, Kaufman DL, Ting GS, Geffner ME. Permanenent diabetes without serological evidence of autoimmunity after transient neonatal diabetes.Diabetes Care 1992; 15:1273–1276.PubMedCrossRefGoogle Scholar
  16. 16.
    Soliman AT, elZalabany MM, Bappal B, alSalmi I, de Silva V Asfour M. Permanent neonatal diabetes mellitus: epidemiology, mode of presentation, pathogenesis and growth.Indian J Pediatr 1999; 66: 363–473.PubMedCrossRefGoogle Scholar
  17. 17.
    Rajadliyiksha SB, Agarwal N, Desai LS. Neonatal diabetes mellitus with severe hypertriglyceridemia.JPEM1996; 9:435–437.Google Scholar
  18. 18.
    Abbate SJL, Brunzell JD. Pathophysiology of hyperlipidemia in diabetes mellitus.J Cardiovasc Pharmacol 1990; 16:1–7.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2002

Authors and Affiliations

  • Zehra Aycan
    • 1
  • Merih Berberoglu
    • 1
  • Gönül Öcal
    • 1
  • Nilgün Altundas
    • 1
  • Pelin Adiyaman
    • 1
  • Okay Evliyaoğlu
    • 1
  1. 1.Department ofPediatric EndocrinologyAnkara University Medical SchoolAnkaraTurkey

Personalised recommendations